Claudia De Lalla

Title: Claudia De Lalla: Innovator in Hematological Research

Introduction

Claudia De Lalla is a prominent inventor based in Milan, Italy. She has made significant contributions to the field of hematological research, particularly through her innovative patents. With a total of 2 patents, her work focuses on the development of therapeutic solutions for hematological disorders.

Latest Patents

One of her latest patents is titled "TCR and uses thereof." This invention relates to a TCR or functional variant that has antigenic specificity for CD1c molecules associated with a self-lipid, preferably mLPA or a derivative thereof. The patent encompasses various applications, including relative polypeptides, proteins, nucleic acids, recombinant expression vectors, host cells, populations of cells, antibodies, and pharmaceutical compositions. The invention is particularly aimed at the treatment and prevention of hematological disorders.

Another notable patent is "Manufacture and use of polypeptides tagged using binding molecules." This invention involves molecules that comprise a polypeptide, such as calmodulin, which has a calcium-dependent binding affinity for a ligand. The molecules are designed for various applications, including detection, immobilization, targeting, purification, cell labeling, and band-shift assays. The invention also explores alternative embodiments involving calmodulin-binding polypeptides derived from mastoparan.

Career Highlights

Claudia has worked with esteemed organizations such as the Medical Research Council and Ospedale San Raffaele S.r.l. Her experience in these institutions has allowed her to advance her research and contribute to significant scientific advancements.

Collaborations

Throughout her career, Claudia has collaborated with notable scientists, including Dario Neri and Gregory Paul Winter. These collaborations have enriched her research and expanded the impact of her inventions.

Conclusion

Claudia De Lalla is a remarkable inventor whose work in hematological research has led to innovative patents that hold promise for the treatment of various disorders. Her contributions continue to influence the field and inspire future research endeavors.